drugset / Trial / NCT01770080
Efficacy of Euminz® for Tension-Type Headache
Phase 4
Completed
211 enrolled
Charite University, Berlin, Germany
Cassella-med GmbH & Co. KG · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Efficacy and safety of Euminz® (10% ethanolic solution of peppermint oil for topical use) compared to placebo in patients with episodic tension-type headache (ETTH). Prospective, double-blind, placebo-controlled, phase IV clinical trial; Parallel-groups design; Randomisation 1:1; First attack per patient will be evaluated for primary objectives, following attacks during study duration will be observed and documented. Study duration per patient: 10 weeks
Timeline
- Start
- 2013-02
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Euminz® | Unknown | 10 % | Topical |